The spread of Coronavirus Disease 2019 (COVID-19) is having a significant impact on people’s lives in our communities and throughout the world. At Berman & Simmons, we are taking this evolving situation very seriously. We’re carefully monitoring the news in Maine and around the U.S. and being proactive in our efforts to stay on top of the COVID-19 crisis. As […]
Berman & Simmons News Articles
-
-
Celebrating Our Youth Leaders: Zamzam Elmoge
Berman & Simmons is proud to honor Zamzam Elmoge as one of our firm’s inaugural Youth Leader Award recipients. Zamzam has known her future lies in film since she was a child, but didn’t know how until after her first summer attending Seeds of Peace, a camp in Maine aimed at teaching children from different backgrounds leadership skills. It […]
-
Patient Safety News: FDA Halts the Sale of Surgical Mesh
The Food and Drug Administration (FDA) has ordered Boston Scientific and Coloplast, the producers of surgical mesh, to stop selling and distributing its products made for treating pelvic organ prolapse (POP) immediately. This decision was reached after thousands of patients filed suit against the companies, blaming the product for painful and often permanent complications, many requiring further surgery. They include […]
-
Patient Safety News: FDA Deliberates Taking Women’s Surgical Mesh Off the Market
The FDA is now considering whether synthetic surgical mesh products used to treat pelvic organ prolapse should remain available to patients. There have been 10,390 reports of injury and 77 deaths linked to the product, also commonly known as vaginal mesh. Thousands of women have filed lawsuits against the medical device manufacturers Boston Scientific and Coloplast Corp, citing the faulty […]
-
Patient Safety News: California Man Awarded $80 Million for Cancer Caused by Roundup Weed Killer
A California jury agreed that routine use of the weed killer Roundup caused the cancer of a 70- year-old man, awarding him $80 million in damages in March 2019. The patient said he regularly used Roundup products in his yard to treat weeds, poison oak and overgrowth and argued that the manufacturer was negligent in not providing sufficient cancer warnings […]
-
Patient Safety News: Patients awarded $775 Million for complications caused by Xarelto
Bayer and Johnson & Johnson, the two manufacturers of the blood thinner Xarelto, will pay $775 million to patients who say they were not informed that the drug could cause deadly bleeding side effects. Xarelto is prescribed to prevent clots that could lead to strokes. There have been 25,000 lawsuits filed against the companies, charging they failed to warn patients […]
-
Patient Safety News: Johnson & Johnson Failed to Warn About Talc Products, Jury Concludes
A jury in Oakland, Calif., has delivered another blow to health and manufacturing giant Johnson & Johnson, with a $29 verdict awarded to a woman who argued the company’s talc powders caused her cancer. The March 13 verdict followed a trial that lasted longer than two months. It was the first talc-related case to go to trial since Reuters reported […]
-
Patient Safety News: FDA Meets on Breast Implants Associated with Causing Cancer
The U.S. Food and Drug Administration (FDA) held a two-day meeting in March 2019 to hear from patients, physicians, manufacturers and other experts about the risk that certain breast implants have in causing cancer. The FDA has received notice of 457 cancer cases from women with the implants through last year. The purpose of the hearings is to determine whether […]